14 rezultatus
The present invention relates to the use of 1-[4-(5-cyanoindol-3-yl)butyl[-4-(2-carbamoyl-benzofuran-5-yl)-piperazine or a physiologically acceptable salt thereof, for the manufacture of a medicament for the treatment of sub-type anxiety
The present invention relates to the use of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine or a physiologically acceptable salt thereof, for the manufacture of a medicament for the treatment of sub-type anxiety
The present invention relates to the use of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine or a physiologically acceptable salt thereof, for the manufacture of a medicament for the treatment of sub-type anxiety
The invention relates to substituted benzofuran-2-carboxamides of the formula I
##STR00002## in which D is H, OH, OA, CN, Hal, COR.sup.3 or CH.sub.2R.sup.3, R.sup.1 is amino, hydroxyl, cyano, --C(.dbd.NR.sup.4)--N(R.sup.4).sub.2, Het, unsubstituted or A-substituted cycloalkyl having from 3 to 10
FIELD OF THE INVENTION
The present invention relates to novel compounds, to processes for preparing them and to their use in treating medical disorders.
BACKGROUND OF THE INVENTION
1-[4-(5-Cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine- , its physiologically acceptable salts
FIELD OF THE INVENTION
The present invention relates to novel compounds, to processes for preparing them and to their use in treating medical disorders.
BACKGROUND OF THE INVENTION
1-[4-(5-Cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine- , its physiologically acceptable salts
FIELD OF THE INVENTION
The present invention relates to novel compounds, to processes for preparing them and to their use in treating medical disorders.
BACKGROUND OF THE INVENTION
1-[4-(5-Cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine- , its physiologically acceptable salts
FIELD OF THE INVENTION
The present invention relates to novel compounds, to processes for preparing them and to their use in treating medical disorders.
BACKGROUND OF THE INVENTION
1-[4-(5-Cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine- , its physiologically acceptable salts
FIELD OF THE INVENTION
The present invention relates to novel compounds, to processes for preparing them and to their use in treating medical disorders.
BACKGROUND OF THE INVENTION
1-[4-(5-Cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine- , its physiologically acceptable salts
FIELD OF THE INVENTION
The present invention relates to novel compounds, to processes for preparing them and to their use in treating medical disorders.
BACKGROUND OF THE INVENTION
1-[4-(5-Cyanoindol-3-yl)butyl]4-(2-carbamoyl-benzofuran-5-yl)-piperazine, its physiologically acceptable salts thereof
FIELD OF THE INVENTION
The present invention relates to novel compounds, to processes for preparing them and to their use in treating medical disorders.
BACKGROUND OF THE INVENTION
1-[4-(5-Cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine- , its physiologically acceptable salts
FIELD OF THE INVENTION
The present invention relates to novel compounds, to processes for preparing them and to their use in treating medical disorders.
BACKGROUND OF THE INVENTION
1-[4-(5-Cyanoindol-3-yl)butyl]-4-(2-carbamoyl -benzofuran-5-yl)-piperazine, its physiologically acceptable salts
FIELD OF THE INVENTION
The present invention relates to novel compounds, to processes for preparing them and to their use in treating medical disorders.
BACKGROUND OF THE INVENTION
1-[4-(5-Cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine- , its physiologically acceptable salts
FIELD OF THE INVENTION
The present invention relates to novel compounds, to processes for preparing them and to their use in treating medical disorders.
BACKGROUND OF THE INVENTION
1-[4-(5-Cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine- , its physiologically acceptable salts